Research progress of perioperative cognitive function changes in patients with ischemic moyamoya disease

doi:10.16352/j.issn.1001-6325.2023.11.1713

Abstract

Abstract: Moyamoya disease (MMD) is a chronic cerebrovascular disease of unknown etiology characterized by progressive stenosis or occlusion of unilateral or bilateral terminal internal carotid arteries, accompanied by the abnormal cerebrovascular network (moyamoya vessels) at the skull base. In recent years, with the continuous improvement of medical technology and research level, the detection rate of peri-operative cognitive changes in MMD patients has gradually increased. This paper reviews the clinical manifestations, pathogenesis and influencing factors of peri-operative cognitive changes in patients with ischemic MMD, and focuses on the electroencephalogram(EEG) and magnetic resonance imaging(MRI) features associated with cognitive impairment in patients with MMD.

Key words: moyamoya disease, cognitive function, electroencephalogram, magnetic resonance, anesthesima

CLC Number:

R651

CHEN Xuanling, QIN Xuewei, LI Zhengqian, ZHAO Xin, YAO Lan, GUO Xiangyang. Research progress of perioperative cognitive function changes in patients with ischemic moyamoya disease[J]. Basic & Clinical Medicine, 2023, 43(11): 1713-1717.

References 24

[1]	Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome[J]. N Engl J Med,2009,360:1226-1237.
[2]	姚紫云,姚飞荣,李文娟,等. 烟雾病的研究进展[J]. 中国血液流变学杂志,2021,31:137-141.
[3]	Berry JA, Cortez V, Toor H, et al. Moyamoya: an update and review[J]. Cureus,2020;12: e10994. doi:10.7759/cureus.10994.
[4]	Shang S, Zhou D, Ya J, et al. Progress in moyamoya disease[J]. Neurosurg Rev,2020,43:371-382.
[5]	He S, Duan R, Liu Z, et al. Characteristics of cognitive impairment in adult asymptomatic moyamoya disease[J]. BMC Neurol,2020,20: 322. doi: 10.1186/s12883-020-01898-8.
[6]	Fujimura M, Tominaga T, Kuroda S, et al.2021 Japanese Guidelines for the management of moyamoya disease: guidelines from the research committee on moyamoya disease and Japan stroke society[J]. Neurol Med Chir (Tokyo),2022,62:165-170.
[7]	Tasbihgou SR, Absalom AR. Postoperative neurocognitive disorders[J]. Korean J Anesthesiol,2021,74:15-22.
[8]	He S,Liu Z, Wei Y, et al. Impairments in brain perfusion,executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic moyamoya disease[J]. BMC Neurosci,2021,22:35. doi: 10.1186/s12868-021-00638-z.
[9]	Sun J, Shi Z, Yu L, et al. Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research[J]. BMC Neurol,2022,22:12. doi: 10.1186/s12883-021-02511-2.
[10]	Liu Z, He S, Wei Y, et al. Changes of cerebral cortical structure and cognitive dysfunction in “healthy hemis-phere” after stroke: a study about cortical complexity and sulcus patterns in bilateral ischemic adult moyamoya disease[J]. BMC Neurosci,2021,22:66. doi: 10.1186/s12868-021-00672-x.
[11]	Deckers PT, Kronenburg A, van den Berg E, et al. Clinical outcome, cognition, and cerebrovascular reactivity after surgical treatment for moyamoya vasculopathy: a dutch prospective, single-center cohort study[J]. J Clin Med,2022,11: 7427-7450.
[12]	Festa JR, Schwarz LR, Pliskin N, et al. Neurocognitive dysfunction in adult moyamoya disease[J]. J Neurol,2010,257:806-815.
[13]	Karzmark P, Zeifert PD, Tan S, et al. Effect of moya-moya disease on neuropsychological functioning in adults[J]. Neurosurgery,2008,62:1048-1052.
[14]	Shi Z, Wen YJ, Huang Z, et al. Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes[J]. Stroke Vasc Neurol,2020,5:86-96.
[15]	Ogasawara K, Uchida S, Akamatsu Y, et al. Outcomes of medical management alone for adult patients with cerebral misery perfusion due to ischemic moyamoya disease[J]. J Stroke Cerebrovasc Dis,2022,31:106588.doi:10.1016/j.jscrokecerebrovasalis.2022.106558.
[16]	Lei Y, Li YJ, Guo QH, et al. Postoperative executive function in adult moyamoya disease: a preliminary study of its functional anatomy and behavioral correlates[J]. J Neurosurg,2017,126:527-536.
[17]	Zeifert PD, Karzmark P, Bell-Stephens TE, et al. Neurocognitive performance after cerebral revascularization in adult moyamoya disease[J]. Stroke,2017,48:1514-1517.
[18]	Bao Y, Yu F, Wei L, et al. Association between cognitive decline and altered cerebral perfusion in adults with moyamoya disease after revascularization[J]. Cerebrovasc Dis,2022,51:764-773.
[19]	Venkatraghavan L, Poublanc J, Bharadwaj S, et al. Noninvasive measurement of cerebral blood flow under anesthesia using arterial spin labeling MRI: a pilot study[J].J Neurosurg Anesthesiol,2016,28:331-336.
[20]	Lang SS, Vollmer E, Wu L, et al. A retrospective study of neurological complications in pediatric patients with moyamoya disease undergoing general anesthesia[J]. Anesth Analg,2021,132:493-499.
[21]	黄祥,韩明明,殷国兵,等.目标导向液体治疗对缺血型烟雾病患者脑血管重建术后谵妄的影响[J].临床麻醉学杂志,2020,36:13-16.
[22]	Noshiro S, Mikami T, Komatsu K, et al. Neuromo-dulatory role of revascularization surgery in moyamoya disease[J]. World Neurosurg,2016,91:473-482.
[23]	Lu J, Xia Q, Yang T, et al. Electroencephalographic features in pediatric patients with moyamoya disease in China[J]. Chin Neurosurg J,2020,6:3.doi:10.1186/s41016-019-0179-2.
[24]	Calviere L, Catalaa I, Marlats F, et al. Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease: clinical article[J]. J Neurosurg,2010,113:753-759.